(Q43591504)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20962740%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

title

Changes in anemia management and hemoglobin levels following revision of a bundling policy to incorporate recombinant human erythropoietin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20962740%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20962740%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

5

Shunichi Fukuhara

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20962740%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

3

Ronald L Pisoni

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20962740%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

6

Takashi Akiba

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20962740%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

9

Tadao Akizawa

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20962740%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

author name string

Jennifer L Bragg-Gresham

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20962740%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Bruce M Robinson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20962740%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Akira Saito

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20962740%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Kiyoshi Kurokawa

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20962740%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

language of work or name

English

0 references

publication date

20 October 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20962740%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20962740%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

volume

79

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20962740%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20962740%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

page(s)

340-346

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20962740%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/ki.2010.382

15 February 2020

exact match

0 references

cites work

Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Canadian Erythropoietin Study Group

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.382

7 January 2021

Correction of anemia with epoetin alfa in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.382

7 January 2021

Associations between Changes in Hemoglobin and Administered Erythropoiesis-Stimulating Agent and Survival in Hemodialysis Patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.382

7 January 2021

Normalization of hemoglobin level in patients with chronic kidney disease and anemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.382

7 January 2021

The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.382

7 January 2021

A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.382

7 January 2021

Translating epoetin research into practice: the role of government and the use of scientific evidence

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.382

7 January 2021

End-stage renal disease and economic incentives: the International Study of Health Care Organization and Financing (ISHCOF).

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.382

7 January 2021

Japanese haemodialysis anaemia management practices and outcomes (1999-2006): results from the DOPPS.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.382

7 January 2021

2004 Japanese Society for Dialysis Therapy guidelines for renal anemia in chronic hemodialysis patients.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.382

7 January 2021

Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS).

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.382

7 January 2021

International trends in erythropoietin use and hemoglobin levels in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.382

7 January 2021

Anaemia management in patients with chronic kidney disease: a position statement by the Anaemia Working Group of European Renal Best Practice (ERBP).

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.382

7 January 2021

Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.382

7 January 2021

Five-year survival for end-stage renal disease patients in the United States, Europe, and Japan, 1982 to 1987.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.382

7 January 2021

Dialysis facility ownership and epoetin dosing in patients receiving hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.382

7 January 2021

II. Clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease in adults

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.382

7 January 2021

EPO adjustments in patients with elevated hemoglobin levels: provider practice patterns compared with recommended practice guidelines.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.382

7 January 2021

Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.382

7 January 2021

Ferric gluconate reduces epoetin requirements in hemodialysis patients with elevated ferritin

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.382

7 January 2021

Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.382

7 January 2021

Iron storage indices: novel predictors of bacteremia in hemodialysis patients initiating intravenous iron therapy.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.382

7 January 2021

Does iron reduction improve sustained viral responses to interferon monotherapy in hepatitis C patients? Maybe, but is this the right question?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.382

7 January 2021

Identifiers

DOI

10.1038/KI.2010.382

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20962740%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference